Gga-miR-155 Enhances Type I Interferon Expression and Suppresses Infectious Burse Disease Virus Replication via Targeting SOCS1 and TANK

Frontiers in Cellular and Infection Microbiology - Switzerland
doi 10.3389/fcimb.2018.00055
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Frontiers Media SA

Related search

Hepatitis C Virus Driven AXL Expression Suppresses the Hepatic Type I Interferon Response

PLoS ONE
Multidisciplinary
2015English

MiR-155 Modulates the Inflammatory Phenotype of Intestinal Myofibroblasts by Targeting SOCS1 in Ulcerative Colitis

Experimental & Molecular Medicine
2015English

Interferon Alpha Treatment Stimulates Interferon Gamma Expression in Type I NKT Cells and Enhances Their Antiviral Effect Against Hepatitis C Virus

PLoS ONE
Multidisciplinary
2017English

Downregulation of MicroRNA Hsa-miR-340-5p in Influenza a Virus Infected A549 Cells Suppresses Viral Replication by Targeting RIG-I and OAS2

Molecular Therapy - Nucleic Acids
Drug DiscoveryMolecular Medicine
2019English

NT21MP Negatively Regulates Paclitaxel-Resistant Cells by Targeting miR‑155‑3p and miR‑155-5p via the CXCR4 Pathway in Breast Cancer

International Journal of Oncology
Cancer ResearchOncology
2018English

miR-127 Suppresses Gastric Cancer Cell Migration and Invasion via Targeting Wnt7a

Oncology Letters
Cancer ResearchOncology
2019English

Resveratrol Upregulates SOCS1 Production by Lipopolysaccharide-Stimulated RAW264.7 Macrophages by Inhibiting miR-155

International Journal of Molecular Medicine
MedicineGenetics
2016English

Porcine Reproductive and Respiratory Syndrome Virus Nsp11 Antagonizes Type I Interferon Signaling by Targeting IRF9

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
2019English

Targeting miR-155 to Treat Experimental Scleroderma

Scientific Reports
Multidisciplinary
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy